Mivacurium

Generic Name
Mivacurium
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C58H80N2O14
CAS Number
133814-19-4
Unique Ingredient Identifier
77D66S9Q93
Background

Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission.

Indication

For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions
-
Associated Therapies
Curarization therapy, General Anesthesia, Neuromuscular blocking therapy, Facilitation of small bowel intubation therapy, Smooth muscle relaxation prior to radiological procedures therapy

Muscle Relaxant Effect and Safety of Mivacurium Chloride and Succinylcholine for Bronchoscopy

First Posted Date
2024-11-29
Last Posted Date
2024-11-29
Lead Sponsor
Peng Liang
Target Recruit Count
240
Registration Number
NCT06709066

Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients

First Posted Date
2022-09-28
Last Posted Date
2023-11-07
Lead Sponsor
Matias Vested
Target Recruit Count
70
Registration Number
NCT05558137
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis

Phase 2
Conditions
Interventions
First Posted Date
2015-06-16
Last Posted Date
2015-08-21
Lead Sponsor
Tang-Du Hospital
Target Recruit Count
80
Registration Number
NCT02473601
Locations
🇨🇳

Tangdu hospital, Xi'an, Shanxi, China

Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy

First Posted Date
2013-10-21
Last Posted Date
2014-07-30
Lead Sponsor
Dr. Horst Schmidt Klinik GmbH
Target Recruit Count
100
Registration Number
NCT01966484
Locations
🇩🇪

Dr. Horst Schmidt Klinik GmbH, Wiesbaden, Germany

Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-07-24
Last Posted Date
2014-04-11
Lead Sponsor
University of California, San Francisco
Target Recruit Count
20
Registration Number
NCT01906528
Locations
🇺🇸

University of California, UCSF, San Francisco, California, United States

© Copyright 2024. All Rights Reserved by MedPath